Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...

Relapsing-remitting multiple sclerosis is an unpredictable disease marked by relapses and remissions, but there are options ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...

Researchers at the University of Colorado Anschutz Medical Campus have found a promising drug candidate that could help restore vision in individuals with multiple sclerosis (MS) and other ...

The FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa. The US Food and Drug ...

Pregnant people with multiple sclerosis (MS) have a higher chance of experiencing mental illness both during their pregnancy and in the first years after they give birth than those without MS, ...

Multiple sclerosis (MS) is an autoimmune neurological ... Both conditions require a variety of medical tests for a diagnosis. Before you begin any tests, you may be able to distinguish your ...